GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Redcare Pharmacy NV (XTER:RDC) » Definitions » Capex-to-Revenue

Redcare Pharmacy NV (XTER:RDC) Capex-to-Revenue : 0.02 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Redcare Pharmacy NV Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Redcare Pharmacy NV's Capital Expenditure for the three months ended in Sep. 2024 was €-9.78 Mil. Its Revenue for the three months ended in Sep. 2024 was €574.55 Mil.

Hence, Redcare Pharmacy NV's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.02.


Redcare Pharmacy NV Capex-to-Revenue Historical Data

The historical data trend for Redcare Pharmacy NV's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redcare Pharmacy NV Capex-to-Revenue Chart

Redcare Pharmacy NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.06 0.04 0.04 0.02

Redcare Pharmacy NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.02

Competitive Comparison of Redcare Pharmacy NV's Capex-to-Revenue

For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redcare Pharmacy NV's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Redcare Pharmacy NV's Capex-to-Revenue falls into.



Redcare Pharmacy NV Capex-to-Revenue Calculation

Redcare Pharmacy NV's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-38.221) / 1798.758
=0.02

Redcare Pharmacy NV's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-9.778) / 574.548
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Redcare Pharmacy NV  (XTER:RDC) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Redcare Pharmacy NV Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Redcare Pharmacy NV's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Redcare Pharmacy NV Business Description

Traded in Other Exchanges
Address
Erik de Rodeweg 11/13, Sevenum, NLD, 5975 WD
Redcare Pharmacy NV operates an online pharmacy store. Its product portfolio is focused on prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue domestically from the DACH segment. Geographically, it has a presence in Germany, Austria, Switzerland, Netherlands, Belgium, Spain, France, and Italy.
Executives
Theresa Margarete Holler Board of Directors
Frank Köhler Supervisory Board
Marc Michael Fischer Board of Directors
Stephan Weber Board of Directors
Dr. Björn Söder Supervisory Board
Jerome Cochet Supervisory Board
Jan Claudius Pyttel Supervisory Board

Redcare Pharmacy NV Headlines